The top 5 R&D expenses for the first half of 2020 were:BeiGene, China Biopharmaceutical, Hengrui Pharmaceutical, Fosun Pharmaceutical, Shiyao Group, R&D investment is over 1 billion yuan!
Edit/Elisa
2020年上半年研发支Top5分别为:百济神州、中国生物制药、恒瑞医药、复星医药、石药集团,研发投入均超过10亿元!
编辑/elisa
The top 5 R&D expenses for the first half of 2020 were:BeiGene, China Biopharmaceutical, Hengrui Pharmaceutical, Fosun Pharmaceutical, Shiyao Group, R&D investment is over 1 billion yuan!
Edit/Elisa
The translation is provided by third-party software.
Use the share button in your browser
to share the page with your friends